Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a

G9a is a histone lysine methyltransferase responsible for the methylation of histone H3 lysine 9. The discovery of A-366 arose from a unique diversity screening hit, which was optimized by incorporation of a propyl-pyrrolidine subunit to occupy the enzyme lysine channel. A-366 is a potent inhibitor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACS medicinal chemistry letters 2014-02, Vol.5 (2), p.205-209
Hauptverfasser: Sweis, Ramzi F, Pliushchev, Marina, Brown, Peter J, Guo, Jun, Li, Fengling, Maag, David, Petros, Andrew M, Soni, Nirupama B, Tse, Chris, Vedadi, Masoud, Michaelides, Michael R, Chiang, Gary G, Pappano, William N
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 209
container_issue 2
container_start_page 205
container_title ACS medicinal chemistry letters
container_volume 5
creator Sweis, Ramzi F
Pliushchev, Marina
Brown, Peter J
Guo, Jun
Li, Fengling
Maag, David
Petros, Andrew M
Soni, Nirupama B
Tse, Chris
Vedadi, Masoud
Michaelides, Michael R
Chiang, Gary G
Pappano, William N
description G9a is a histone lysine methyltransferase responsible for the methylation of histone H3 lysine 9. The discovery of A-366 arose from a unique diversity screening hit, which was optimized by incorporation of a propyl-pyrrolidine subunit to occupy the enzyme lysine channel. A-366 is a potent inhibitor of G9a (IC50: 3.3 nM) with greater than 1000-fold selectivity over 21 other methyltransferases.
doi_str_mv 10.1021/ml400496h
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4027767</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1534102386</sourcerecordid><originalsourceid>FETCH-LOGICAL-a471t-8122ea0f9df305eeec6fa11516c28c07e2428845b2c989b513a0de57c4d3fa9c3</originalsourceid><addsrcrecordid>eNptkVFLwzAUhYMobk4f_APSF0EfpkmaNsmLIJtug4mC-ighS29dR9vMJCvs39uxORR8uhfOx7mHcxE6J_iGYEpuq5JhzGQ6P0BdIpnoJ4Inh7_2DjrxfoFxKjnHx6hDmcRYYNJFH8PCG9uAW0e6zqIhNFDaZQV1iGwevdiw2TbKK5RgQtFANKnnxawI1vkNMi58sDVETxDm6zI4XfscnPYQjaQ-RUe5Lj2c7WYPvT8-vA3G_enzaDK4n_Y14yT0BaEUNM5llsc4AQCT5pqQhKSGCoM5UEaFYMmMGinkLCGxxhkk3LAszrU0cQ_dbX2Xq1kFmWlDO12qpSsq7dbK6kL9Vepirj5toximnKe8NbjaGTj7tQIfVNX2AmWpa7Arr0gSs7bqWKQter1FjbPeO8j3ZwhWm3eo_Tta9uJ3rj35038LXG4Bbbxa2JWr25r-MfoG-ESTSw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1534102386</pqid></control><display><type>article</type><title>Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a</title><source>ACS Publications</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Sweis, Ramzi F ; Pliushchev, Marina ; Brown, Peter J ; Guo, Jun ; Li, Fengling ; Maag, David ; Petros, Andrew M ; Soni, Nirupama B ; Tse, Chris ; Vedadi, Masoud ; Michaelides, Michael R ; Chiang, Gary G ; Pappano, William N</creator><creatorcontrib>Sweis, Ramzi F ; Pliushchev, Marina ; Brown, Peter J ; Guo, Jun ; Li, Fengling ; Maag, David ; Petros, Andrew M ; Soni, Nirupama B ; Tse, Chris ; Vedadi, Masoud ; Michaelides, Michael R ; Chiang, Gary G ; Pappano, William N</creatorcontrib><description>G9a is a histone lysine methyltransferase responsible for the methylation of histone H3 lysine 9. The discovery of A-366 arose from a unique diversity screening hit, which was optimized by incorporation of a propyl-pyrrolidine subunit to occupy the enzyme lysine channel. A-366 is a potent inhibitor of G9a (IC50: 3.3 nM) with greater than 1000-fold selectivity over 21 other methyltransferases.</description><identifier>ISSN: 1948-5875</identifier><identifier>EISSN: 1948-5875</identifier><identifier>DOI: 10.1021/ml400496h</identifier><identifier>PMID: 24900801</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Letter</subject><ispartof>ACS medicinal chemistry letters, 2014-02, Vol.5 (2), p.205-209</ispartof><rights>Copyright © 2014 American Chemical Society</rights><rights>Copyright © 2014 American Chemical Society 2014 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a471t-8122ea0f9df305eeec6fa11516c28c07e2428845b2c989b513a0de57c4d3fa9c3</citedby><cites>FETCH-LOGICAL-a471t-8122ea0f9df305eeec6fa11516c28c07e2428845b2c989b513a0de57c4d3fa9c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/ml400496h$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/ml400496h$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,2752,27053,27901,27902,53766,53768,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24900801$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sweis, Ramzi F</creatorcontrib><creatorcontrib>Pliushchev, Marina</creatorcontrib><creatorcontrib>Brown, Peter J</creatorcontrib><creatorcontrib>Guo, Jun</creatorcontrib><creatorcontrib>Li, Fengling</creatorcontrib><creatorcontrib>Maag, David</creatorcontrib><creatorcontrib>Petros, Andrew M</creatorcontrib><creatorcontrib>Soni, Nirupama B</creatorcontrib><creatorcontrib>Tse, Chris</creatorcontrib><creatorcontrib>Vedadi, Masoud</creatorcontrib><creatorcontrib>Michaelides, Michael R</creatorcontrib><creatorcontrib>Chiang, Gary G</creatorcontrib><creatorcontrib>Pappano, William N</creatorcontrib><title>Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a</title><title>ACS medicinal chemistry letters</title><addtitle>ACS Med. Chem. Lett</addtitle><description>G9a is a histone lysine methyltransferase responsible for the methylation of histone H3 lysine 9. The discovery of A-366 arose from a unique diversity screening hit, which was optimized by incorporation of a propyl-pyrrolidine subunit to occupy the enzyme lysine channel. A-366 is a potent inhibitor of G9a (IC50: 3.3 nM) with greater than 1000-fold selectivity over 21 other methyltransferases.</description><subject>Letter</subject><issn>1948-5875</issn><issn>1948-5875</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNptkVFLwzAUhYMobk4f_APSF0EfpkmaNsmLIJtug4mC-ighS29dR9vMJCvs39uxORR8uhfOx7mHcxE6J_iGYEpuq5JhzGQ6P0BdIpnoJ4Inh7_2DjrxfoFxKjnHx6hDmcRYYNJFH8PCG9uAW0e6zqIhNFDaZQV1iGwevdiw2TbKK5RgQtFANKnnxawI1vkNMi58sDVETxDm6zI4XfscnPYQjaQ-RUe5Lj2c7WYPvT8-vA3G_enzaDK4n_Y14yT0BaEUNM5llsc4AQCT5pqQhKSGCoM5UEaFYMmMGinkLCGxxhkk3LAszrU0cQ_dbX2Xq1kFmWlDO12qpSsq7dbK6kL9Vepirj5toximnKe8NbjaGTj7tQIfVNX2AmWpa7Arr0gSs7bqWKQter1FjbPeO8j3ZwhWm3eo_Tta9uJ3rj35038LXG4Bbbxa2JWr25r-MfoG-ESTSw</recordid><startdate>20140213</startdate><enddate>20140213</enddate><creator>Sweis, Ramzi F</creator><creator>Pliushchev, Marina</creator><creator>Brown, Peter J</creator><creator>Guo, Jun</creator><creator>Li, Fengling</creator><creator>Maag, David</creator><creator>Petros, Andrew M</creator><creator>Soni, Nirupama B</creator><creator>Tse, Chris</creator><creator>Vedadi, Masoud</creator><creator>Michaelides, Michael R</creator><creator>Chiang, Gary G</creator><creator>Pappano, William N</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140213</creationdate><title>Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a</title><author>Sweis, Ramzi F ; Pliushchev, Marina ; Brown, Peter J ; Guo, Jun ; Li, Fengling ; Maag, David ; Petros, Andrew M ; Soni, Nirupama B ; Tse, Chris ; Vedadi, Masoud ; Michaelides, Michael R ; Chiang, Gary G ; Pappano, William N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a471t-8122ea0f9df305eeec6fa11516c28c07e2428845b2c989b513a0de57c4d3fa9c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Letter</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sweis, Ramzi F</creatorcontrib><creatorcontrib>Pliushchev, Marina</creatorcontrib><creatorcontrib>Brown, Peter J</creatorcontrib><creatorcontrib>Guo, Jun</creatorcontrib><creatorcontrib>Li, Fengling</creatorcontrib><creatorcontrib>Maag, David</creatorcontrib><creatorcontrib>Petros, Andrew M</creatorcontrib><creatorcontrib>Soni, Nirupama B</creatorcontrib><creatorcontrib>Tse, Chris</creatorcontrib><creatorcontrib>Vedadi, Masoud</creatorcontrib><creatorcontrib>Michaelides, Michael R</creatorcontrib><creatorcontrib>Chiang, Gary G</creatorcontrib><creatorcontrib>Pappano, William N</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ACS medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sweis, Ramzi F</au><au>Pliushchev, Marina</au><au>Brown, Peter J</au><au>Guo, Jun</au><au>Li, Fengling</au><au>Maag, David</au><au>Petros, Andrew M</au><au>Soni, Nirupama B</au><au>Tse, Chris</au><au>Vedadi, Masoud</au><au>Michaelides, Michael R</au><au>Chiang, Gary G</au><au>Pappano, William N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a</atitle><jtitle>ACS medicinal chemistry letters</jtitle><addtitle>ACS Med. Chem. Lett</addtitle><date>2014-02-13</date><risdate>2014</risdate><volume>5</volume><issue>2</issue><spage>205</spage><epage>209</epage><pages>205-209</pages><issn>1948-5875</issn><eissn>1948-5875</eissn><abstract>G9a is a histone lysine methyltransferase responsible for the methylation of histone H3 lysine 9. The discovery of A-366 arose from a unique diversity screening hit, which was optimized by incorporation of a propyl-pyrrolidine subunit to occupy the enzyme lysine channel. A-366 is a potent inhibitor of G9a (IC50: 3.3 nM) with greater than 1000-fold selectivity over 21 other methyltransferases.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>24900801</pmid><doi>10.1021/ml400496h</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1948-5875
ispartof ACS medicinal chemistry letters, 2014-02, Vol.5 (2), p.205-209
issn 1948-5875
1948-5875
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4027767
source ACS Publications; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Letter
title Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T18%3A25%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discovery%20and%20Development%20of%20Potent%20and%20Selective%20Inhibitors%20of%20Histone%20Methyltransferase%20G9a&rft.jtitle=ACS%20medicinal%20chemistry%20letters&rft.au=Sweis,%20Ramzi%20F&rft.date=2014-02-13&rft.volume=5&rft.issue=2&rft.spage=205&rft.epage=209&rft.pages=205-209&rft.issn=1948-5875&rft.eissn=1948-5875&rft_id=info:doi/10.1021/ml400496h&rft_dat=%3Cproquest_pubme%3E1534102386%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1534102386&rft_id=info:pmid/24900801&rfr_iscdi=true